Axel Bolte is the founder of Inozyme. Inozyme has raised $116M in total funding. Latest round: Series A. Based in Cambridge, United States.
Axel Bolte is the co-founder, President, and CEO of Inozyme Pharma, a biotechnology company founded in 2016 in Cambridge, Massachusetts. He led the company through several financing rounds before its acquisition by BioMarin Pharmaceutical in May 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide